Skip to content

Post-operative longitudinal monitoring of osteochondral defects of the talus with ultrasound after bone marrow stimulation.

Post-operative longitudinal monitoring of osteochondral defects of the talus with ultrasound after bone marrow stimulation. - Monitoring of talar OCD with US after BMS

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45273
Enrollment
5
Registered
2017-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteochondral defect / cartilage defect

Interventions

Sponsors

Orthopedie
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: -Patients should have an age 18 years or older -Patients should be able to read the patient information -Patients who have received or are scheduled for a routine CT-scan of the ankle which shows an OCD of the ankle and are on the waiting list to receive bone marrow stimulation treatment surgical for the OCD -OCDs grade II-V according to the Berndt-Hardy-Loomer classification located at the anterior section of the talar dome.

Exclusion criteria

Exclusion criteria: -Patients with suspected multiple pathologies in the ankle joint -Patients that are not able to or did not receive a CT-scan -Patients younger than 18 years -Patients who have not signed the informed consent form

Design outcomes

Primary

MeasureTime frame
-Degree of filling of the osteochondral defect over time. -Type and degree of irregularity of cartilage surface -Loomer/Berndt and Harty classification of the lesion (pre-op) -ICRS Cartilage Repair Assessment system -ICRS Grade -Location of the lesion in relation to possible visualisation with ultrasound -Description of characteristic signs of an OCD as visualized by ultrasound at all sample events

Secondary

MeasureTime frame
N.A.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)